Drug Approval | November 13, 2024
EMA grants GMP Certificate of compliance to CuraTeQ biosimilars’ Hyderabad facility
The GMP inspection assessed mammalian and microbial drug substance manufacturing facility sections
The GMP inspection assessed mammalian and microbial drug substance manufacturing facility sections
The Pediatric vaccine portfolio delivered double-digit growth and maintained its market leadership in the private market
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
Data demonstrate the importance of protecting against serious respiratory infections caused by respiratory syncytial virus, human metapneumovirus and COVID-19
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
We now rank 3rd in pharmaceutical production by volume and 14th by value
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
Doses will be ready to ship to applicable European Union (EU) member states as soon as possible upon European Commission (EC) authorization
He has been associated with Caplin Steriles Ltd., Mylan Laboratories Ltd., Caplin Point Laboratories Ltd., Strides Arcolab Ltd. and Novartis Vaccines and Diagnostics
Subscribe To Our Newsletter & Stay Updated
